Publication:
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics".

cris.virtualsource.author-orcide0ab60ee-31d7-4e1c-8d75-3d2ccf2261e6
cris.virtualsource.author-orcidbdb4a1ad-e3a7-4d73-afff-0990131f1ede
cris.virtualsource.author-orcid09b183c2-572b-41f7-9f2c-e731dd0c1430
dc.contributor.authorMohsen, Mona Omar Mahmoud
dc.contributor.authorSousa Augusto, Gilles Anderson
dc.contributor.authorBachmann, Martin
dc.date.accessioned2024-09-20T09:21:08Z
dc.date.available2024-09-20T09:21:08Z
dc.date.issued2020-05-30
dc.description.abstractVaccines need to be rationally designed in order be delivered to the immune system for maximizing induction of dynamic immune responses. Virus-like particles (VLPs) are ideal platforms for such 3D vaccines, as they allow the display of complex and native antigens in a highly repetitive form on their surface and can easily reach lymphoid organs in intact form for optimal activation of B and T cells. Adjusting size and zeta potential may allow investigators to further fine-tune delivery to lymphoid organs. An additional way to alter vaccine transfer to lymph nodes and spleen may be the formulation with micron-sized adjuvants that creates a local depot and results in a slow release of antigen and adjuvant. Ideally, the adjuvant in addition stimulates the innate immune system. The dynamics of the immune response may be further enhanced by inclusion of Toll-like receptor ligands, which many VLPs naturally package. Hence, considering the 3Ds in vaccine development may allow for enhancement of their attributes to tackle complex diseases, not usually amenable to conventional vaccine strategies.
dc.description.numberOfPages14
dc.description.sponsorshipUniversitätsklinik für Rheumatologie, Immunologie und Allergologie
dc.identifier.doi10.7892/boris.147994
dc.identifier.pmid32472710
dc.identifier.publisherDOI10.1111/imr.12863
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/45112
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofImmunological reviews
dc.relation.issn0105-2896
dc.relation.organizationDCD5A442C1C9E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BAD8E17DE0405C82790C4DE2
dc.subjectdelivery design dynamics vaccine virus-like particles
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleThe 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics".
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage168
oaire.citation.issue1
oaire.citation.startPage155
oaire.citation.volume296
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, Immunologie und Allergologie
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, Immunologie und Allergologie
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, Immunologie und Allergologie
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Rheumatologie
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Rheumatologie
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Rheumatologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-12-07 11:08:12
unibe.description.ispublishedpub
unibe.eprints.legacyId147994
unibe.journal.abbrevTitleIMMUNOL REV
unibe.refereedTRUE
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
The 3Ds.pdf
Size:
1.54 MB
Format:
Adobe Portable Document Format
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections